MicroRNA as tools and therapeutics in lung cancer
Explore this paper's citation graph
Summary
An overview of the miRNAs implicated in lung cancer, with an emphasis on their clinical utility, is provided.
- Type
- article
- Published
- 2015-02-19
- Cited by
- 104
- References
- 122
- Access
- Open access
- OpenAlex
- https://openalex.org/W25910758
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:39833764
Keywords
Zinc, Throughput, Table (database), Salt (chemistry), Nanowire
References
- Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes.
- MicroRNA genes are transcribed by RNA polymerase II
- Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide Modifier
- Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer.
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- MicroRNAs in the lung.
- Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis.
- Different exosome cargo from plasma/bronchoalveolar lavage in non‐small‐cell lung cancer
- Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA
- Chemical modification and design of anti-miRNA oligonucleotides
- DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer
- microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
- TP53-independent Function of miR-34a via HDAC1 and p21CIP1/WAF1.
- Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.
- Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice.
- MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells
- MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer.
- Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels
- Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin
- Classification of the four main types of lung cancer using a microRNA-based diagnostic assay.
Cited by
- Synthesis and anti-metastasis activities of norcantharidin-conjugated carboxymethyl chitosan as a novel drug delivery system.
- Use of miRNAs as Biomarkers in Sepsis
- MiR-301a promotes cell proliferation by directly targeting TIMP2 in multiple myeloma.
- Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells
- Suppression of nucleosome-binding protein 1 by miR-326 impedes cell proliferation and invasion in non-small cell lung cancer cells.
- Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance
- Gastric cardia adenocarcinoma microRNA profiling in Chinese patients
- Use of circulating microRNAs as biomarkers in critically ill polytrauma patients
- Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers
- MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway
- MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment
- miR-185 mediates lung epithelial cell death after oxidative stress.
- MicroRNA-376c suppresses non-small-cell lung cancer cell growth and invasion by targeting LRH-1-mediated Wnt signaling pathway.
- The role of microRNA in metastatic processes of non-small cell lung carcinoma.
- MicroRNA-34a inhibits cell proliferation and induces cell apoptosis of glioma cells via targeting of Bcl-2.
- Prostacyclin reverses the cigarette smoke-induced decrease in pulmonary Frizzled 9 expression through miR-31
- Role of plasma MicroRNAs in the early diagnosis of non-small-cell lung cancers: a case-control study.
- Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma.
- Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung cancer cells via upregulation of programmed cell death protein 4.
- MicroRNA-3666-induced suppression of SIRT7 inhibits the growth of non-small cell lung cancer cells.